PDA

View Full Version : Pfizer's response to compound fraud spotlights quality issues - Royal Society of Chem



FraudNews
12-08-2015, 02:50 AM
http://www.fraud-news.com//t2.gstatic.com/images?q=tbn:ANd9GcQikUXYnBrauucTDweqDLvgmV4FMlF7a mYF63cPoLPWrs2QIsGa-BLLIU8SBJcPSspQK8kAiHdF
Royal Society of Chemistry (http://news.google.com/news/url?sa=t&fd=R&ct2=en_za&usg=AFQjCNH_ohOzdANkHbp35RZcVRH6x4QMYA&clid=c3a7d30bb8a4878e06b80cf16b898331&ei=n1NmVsHMJYyW3QGJz6-4Ag&url=http://www.rsc.org/chemistryworld/2015/12/pfizer-bogus-bosutinib-isomer-fraud-leukaemia-drug)


Pfizer's response to compound fraud spotlights quality issues (http://news.google.com/news/url?sa=t&fd=R&ct2=en_za&usg=AFQjCNH_ohOzdANkHbp35RZcVRH6x4QMYA&clid=c3a7d30bb8a4878e06b80cf16b898331&ei=n1NmVsHMJYyW3QGJz6-4Ag&url=http://www.rsc.org/chemistryworld/2015/12/pfizer-bogus-bosutinib-isomer-fraud-leukaemia-drug)
Royal Society of Chemistry
However, this case reflects a worldwide problem, researchers and a supplier affected by the apparent fraud warn. Following this case, LC Laboratories in Woburn, Massachusetts, the first company identified selling bad bosutinib, has thoroughly reviewed ...

[/URL]





[url=http://news.google.com/news/url?sa=t&fd=R&ct2=en_za&usg=AFQjCNH_ohOzdANkHbp35RZcVRH6x4QMYA&clid=c3a7d30bb8a4878e06b80cf16b898331&ei=n1NmVsHMJYyW3QGJz6-4Ag&url=http://www.rsc.org/chemistryworld/2015/12/pfizer-bogus-bosutinib-isomer-fraud-leukaemia-drug]More... (http://news.google.co.za/news/more?ncl=dRA69okBfHoCn8M&authuser=0&ned=en_za)